FDA — authorised 22 April 2008
- Marketing authorisation holder: UCB INC
- Status: approved
FDA authorised Cimzia on 22 April 2008
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 22 April 2008; FDA authorised it on 22 April 2008.
UCB INC holds the US marketing authorisation.